Literature DB >> 8567971

Murine V lambda x and V lambda x-containing antibodies bind human myelin basic protein.

F S Galin1, C C Maier, S R Zhou, J N Whitaker, J E Blalock.   

Abstract

Myelin basic protein (MBP) is highly immunogenic and a known autoantigen capable of inducing experimental allergic encephalomyelitis (EAE), the animal model of multiple sclerosis. We have previously described a murine monoclonal antibody (mAb), F28C4, directed against the encephalitogenic MBP peptide acetyl (Ac) 1-9, which contains a V lambda x light chain. Considering the rarity of V lambda x usage, we determined whether other Abs having V lambda x light chains shared similar antigen (Ag) specificity. We screened a panel of V lambda x-containing monoclonal and polyclonal Abs, of unknown specificity for reactivity with MBP. All such Ab, but not heavy chain isotype matched controls, bound MBP but were not polyreactive with other potential self Ags. The binding of a recombinant form of V lambda x alone to MBP demonstrated the important contribution of the V lambda x light chain to the reaction. With the exception of mAb F28C4 which recognizes MBP Ac1-9, the epitope specificity of all other V lambda x-bearing Abs was localized to MBP residues 25-34. These results demonstrate a unique association between V lambda x expression and MBP reactivity. Given that V lambda x shares sequence homology with T cell receptors (TCR) from encephalitogenic T lymphocytes, these results imply a potential role for V lambda x in the pathogenesis of EAE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567971      PMCID: PMC507041          DOI: 10.1172/JCI118439

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein.

Authors:  D D Wood; M A Moscarello
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

2.  Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli.

Authors:  E S Ward; D Güssow; A D Griffiths; P T Jones; G Winter
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

3.  IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  The antibody response to myelin basic protein (BP) in Lewis rats: the effect of time, dosage of BP, and dosage of Mycobacterium butyricum.

Authors:  E D Day; O M Pitts
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

5.  Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.

Authors:  J A Killen; R H Swanborg
Journal:  J Neuroimmunol       Date:  1982-10       Impact factor: 3.478

6.  A new V gene expressed in lambda-2 light chains of the mouse.

Authors:  R Dildrop; A Gause; W Müller; K Rajewsky
Journal:  Eur J Immunol       Date:  1987-05       Impact factor: 5.532

Review 7.  Monoclonal and polyclonal antibodies to myelin basic protein determinants.

Authors:  E D Day; N T Potter
Journal:  J Neuroimmunol       Date:  1986-02       Impact factor: 3.478

8.  Structure of a third murine immunoglobulin lambda light chain variable region that is expressed in laboratory mice.

Authors:  P Sanchez; P N Marche; C Le Guern; P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis.

Authors:  S S Zamvil; D J Mitchell; A C Moore; K Kitamura; L Steinman; J B Rothbard
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

10.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  7 in total

1.  Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.

Authors:  Jeffrey E Lee; Ana Kuehne; Dafna M Abelson; Marnie L Fusco; Mary Kate Hart; Erica Ollmann Saphire
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

2.  B cell receptor light chain repertoires show signs of selection with differences between groups of healthy individuals and SLE patients.

Authors:  Nathan Schoettler; Dongyao Ni; Martin Weigert
Journal:  Mol Immunol       Date:  2012-04-18       Impact factor: 4.407

3.  Dissociation of the Dimer of the Intrinsically Disordered Domain of RNase Y upon Antibody Binding.

Authors:  Pierre Hardouin; Christophe Velours; Charles Bou-Nader; Nadine Assrir; Soumaya Laalami; Harald Putzer; Dominique Durand; Béatrice Golinelli-Pimpaneau
Journal:  Biophys J       Date:  2018-10-26       Impact factor: 4.033

4.  Antibodies that bind complex glycosaminoglycans accumulate in the Golgi.

Authors:  Marko Radic; Martin G Weigert; Salar N Khan; Jiong Han; Olga Kalinina; Eline T Luning Prak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

5.  Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction.

Authors:  Esther J Witsch; Hong Cao; Hidehiro Fukuyama; Martin Weigert
Journal:  J Exp Med       Date:  2006-06-26       Impact factor: 14.307

6.  Editing anti-DNA B cells by Vlambdax.

Authors:  Yijin Li; Yoram Louzoun; Martin Weigert
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

7.  Light chain editors of anti-DNA receptors in human B cells.

Authors:  Olga Kalinina; Yue Wang; Kevin Sia; Marko Radic; Pierre-André Cazenave; Martin Weigert
Journal:  J Exp Med       Date:  2014-01-27       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.